Alcon AG (ALC)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jul 07, 2025

$87.37

P/E Ratio

34.68

Market Cap

$43.66B

Description
Add to research
View more

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Metrics
Add to research
View more

Overview

  • HQGeneva, GE
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerALC
  • Price$87.366814-0.75%

Trading Information

  • Market cap$43.66B
  • Float98.93%
  • Average Daily Volume (1m)933,080
  • Average Daily Volume (3m)1,048,163
  • EPS$2.01

Company

  • Revenue$8.80B
  • Rev growth (1yr)3.40%
  • Net income$314.64M
  • Gross margin55.92%
  • EBITDA margin31.99%
  • EBITDA$711.09M
  • EV$44.81B
  • EV/Revenue5.09
  • P/E34.68
  • P/S3.94
  • P/B1.77
  • Debt/Equity23.65
Documents
Add to research
View more